%20(1).webp)
- Goal: Revolutionise the manufacture of personalised polypills
- Challenge: Overcoming inefficiencies in current pill production processes
- Solution: Robotic automated system for the production of personalised polypills
- Funds Secured: £699,030 in grant funding
Introduction to ID-Health
ID-Health, in collaboration with AVIDA Medical, is pioneering the frontier of medical innovation. Their mission: to disrupt the traditional pharmaceutical manufacturing sector by introducing a ground-breaking robotic automated system for the production of personalised polypills for cardiovascular disease (CVD) care.
Problem
In the realm of pharmaceutical manufacturing, the production of polypills - a single pill that combines multiple doses of medications - is marred by inefficiency, manual labour-intensive processes, and a lack of scalability. These challenges are especially pronounced in the UK, where most businesses outsource polypill production, leading to increased costs and complexities.
Opportunity
ID-Health identified a significant opportunity to innovate in this space. By developing a miniaturised ‘benchtop’ autoclave, they aim to transform the landscape of composite manufacture, making it accessible to SMEs and large corporations alike. Their solution promises a seismic shift in the industry, enabling engineers and designers to manufacture high-quality composite parts in-house.
Solution
The solution involves a fusion of existing capsule-filling technologies with digital dosing automation. This innovative approach allows for the scalable, flexible production of capsules containing 3 to 7 drugs, customised according to individual patient prescriptions. This level of personalisation, unprecedented at scale, is set to redefine the standards of efficient and effective healthcare.
Challenge
The primary challenge lies in the project's complexity and the need for substantial investment. Securing grant funding became a pivotal step for ID-Health, crucial for turning their visionary concept into a viable, market-ready solution.
Why They Chose Grant Up: ID-Health turned to Grant Up for their proven expertise in securing technology grants and their impressive track record in navigating the intricate landscape of grant applications. Grant Up's ability to understand and articulate the transformative potential of ID-Health's project was instrumental in the funding process.
Result
The collaboration between ID-Health, AVIDA Medical, and Grant Up was a triumph, securing £699,030 in grant funding. This substantial financial support has propelled ID-Health into the next phase of development, bringing them closer to revolutionising personalised polypill manufacturing. The project stands as a testament to the power of innovation, collaboration, and strategic funding in driving healthcare advancements.